Pfizer's chief development officer, Rod MacKenzie, is the Big Pharma's second executive to retire in early 2022. NIH Director Francis Collins will also hit the exit, before the end of this year. Sanofi poaches Gilead cancer executive Valeria Fantin to run its oncology research.
FDA's vaccines office is now headed by Peter Marks after the agency's top two vaccine officials questioned the need for booster doses last month as they head toward the exit later this fall. Houston biotech incubator Sporos Biosciences snagged ex-Ovid Therapeutics Chief Medical Officer Amit Rakhit as its new CEO. In spinning off its gene therapy unit, Amicus' CEO will head to the new company being launched via a SPAC.
hub begin, biotech ceo, running against bob menendez who barely escaped conviction of corruption charges. it might be too long a reach. democrats are willing to give a republican a chance in new jersey. still ahead, with 87 of nation s 99 legislative changes up for re-election, we ll look what is at stake in the states on tuesday. next.